作者
Alba Manuel-Vázquez, Anita Balakrishnan, Paul Agami, Bodil Andersson, Frederik Berrevoet, Marc G Besselink, Ugo Boggi, Damiano Caputo, Alberto Carabias, Lucia Carrion-Alvarez, Carmen Cepeda Franco, Alessandro Coppola, Bobby VM Dasari, Sherley Diaz-Mercedes, Michail Feretis, Constantino Fondevila, Giuseppe Kito Fusai, Giuseppe Garcea, Victor Gonzabay, Miguel Ángel Gómez Bravo, Myrte Gorris, Bart Hendrikx, Camila Hidalgo-Salinas, Prashant Kadam, Dimitrios Karavias, Emanuele Kauffmann, Amar Kourdouli, Vincenzo La Vaccara, Stijn van Laarhoven, James Leighton, Mike SL Liem, Nikolaos Machairas, Dimitris Magouliotis, Adel Mahmoud, Marco V Marino, Marco Massani, Paola Melgar Requena, Keno Mentor, Niccolò Napoli, Jorieke HT Nijhuis, Andrej Nikov, Cristina Nistri, Victor Nunes, Eduardo Ortiz Ruiz, Sanjay Pandanaboyana, Baltasar Pérez Saborido, Radek Pohnán, Mariuca Popa, Belinda Sánchez Pérez, Francisco Sánchez Bueno, Alejandro Serrablo, Mario Serradilla-Martín, James RA Skipworth, Kjetil Soreide, Dimitris Symeonidis, Dimitris Zacharoulis, Piotr Zelga, Daniel Aliseda, María Jesús Castro Santiago, Carlos Fernández Mancilla, Raquel Latorre Fragua, Daniel Llwyd Hughes, Carmen Payá Llorente, Mickaël Lesurtel, Tom Gallagher, José Manuel Ramia, Scientific, Research Committee of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA)
发表日期
2022/12
期刊
Langenbeck's Archives of Surgery
卷号
407
期号
8
页码范围
3447-3455
出版商
Springer Berlin Heidelberg
简介
Purpose
A preoperative estimate of the risk of malignancy for intraductal papillary mucinous neoplasms (IPMN) is important. The present study carries out an external validation of the Shin score in a European multicenter cohort.
Methods
An observational multicenter European study from 2010 to 2015. All consecutive patients undergoing surgery for IPMN at 35 hospitals with histological-confirmed IPMN were included.
Results
A total of 567 patients were included. The score was significantly associated with the presence of malignancy (p < 0.001). In all, 64% of the patients with benign IPMN had a Shin score < 3 and 57% of those with a diagnosis of malignancy had a score ≥ 3. The relative risk (RR) with a Shin score of 3 was 1.37 (95% CI: 1.07–1.77), with a sensitivity of 57.1% and specificity of 64.4%.
Conclusion
Patients with a Shin score ≤ 1 should undergo surveillance, while patients with a score ≥ 4 …
学术搜索中的文章
A Manuel-Vázquez, A Balakrishnan, P Agami… - Langenbeck's Archives of Surgery, 2022